The report will be delivered in 2-3 business days.

Antiobesity Drugs Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : October 2019 | SKU CODE : 7076 | Format :


The anti-obesity drugs market consists of sales of anti-obesity drugs and related services. This industry includes establishments that produce pharmacological agents that reduce or control overweight.

The global antiobesity market was valued at about $1.3 billion in 2018 and is expected to grow to $3.44 billion at a CAGR of 27.5% through 2022.

The anti-obesity drugs market has been geographically segmented into North America, Western Europe, APAC, Eastern Europe, South America and Middle East & Africa. The North American market is the largest market for anti-obesity drugs and is expected to continue to be the largest market during the forecast period.

Obesity is a major public health concern globally. Globally, prevalence rate of obesity is increasing every year. According to WHO, in 2016, more than 1.9 billion adults over the age of 18 years were overweight of which over 650 million were obese. This can be attributed to increased consumption of processed and unhealthy food, lack of physical activity and lack of awareness on the risks of obesity. As a result, the demand for anti-obesity drugs is bound to increase in the future thus, driving market growth.

Obesity is a major health problem worldwide which is caused from leading a sedentary lifestyle and consumption of unhealthy food. Though various anti-obesity drugs have been approved and are available in the USA, European Union, Australia, and Japan to treat obesity and overweight. It has been observed that these drugs have various adverse effects on patients undergoing treatment for obesity. Adverse effects include low blood pressure and blood glucose, incontinence, insomnia, nausea, diarrhea and others. For instance, Sibutramine and its combination drugs sold under various brands was recalled in various countries due to various side effects including heart attack in consumers. These factors restraint the growth of anti-obesity drugs market.

Pharmaceutical industry is witnessing an increase in the number of mergers and acquisition among companies developing drugs for metabolic disorders such as obesity, diabetes and others. This is a strategy of pharmaceutical companies to strengthen their drug portfolio in metabolic diseases and launch safe and effective drugs in the market. For instance, in 2018, Evotec AG and Novo Nordisk entered into a strategic alliance to be able to discover and develop drug molecules to treat metabolic disorders including obesity, diabetes and other associated disorders.

Major players in the market are F. Hoffmann-La Roche AG, , GlaxoSmithKline PLC, , Boehringer Ingelheim GmbH, and Pfizer Inc.

    1. Executive Summary

    2. Anti-obesity Drugs Market Characteristics

    3. Anti-obesity Drugs Market Size And Growth

    3.1. Global Anti-obesity Drugs Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Anti-obesity Drugs Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Anti-obesity Drugs Market Segmentation

    4.1. Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Peripherally acting anti obesity drugs

    Centrally acting anti obesity drugs

    4.2. Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Prescription Drugs (Rx)

    OTC Drugs

    4.3. Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Monotherapies

    Polytherapies

    5. Anti-obesity Drugs Market Regional And Country Analysis

    5.1. Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Anti-obesity Drugs Market  

    6.1. Asia-Pacific Anti-obesity Drugs Market Overview  

    6.2. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Anti-obesity Drugs Market  

    7.1. China Anti-obesity Drugs Market Overview  

    7.2. China Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Anti-obesity Drugs Market  

    8.1. India Anti-obesity Drugs Market Overview  

    8.2. India Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Anti-obesity Drugs Market  

    9.1. Japan Anti-obesity Drugs Market Overview  

    9.2. Japan Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Anti-obesity Drugs Market  

    10.1. Australia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Anti-obesity Drugs Market  

    11.1. Indonesia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Anti-obesity Drugs Market  

    12.1. South Korea Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Anti-obesity Drugs Market  

    13.1. Western Europe Anti-obesity Drugs Market Overview

    13.2. Western Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Anti-obesity Drugs Market  

    14.1. UK Anti-obesity Drugs Market Overview

    14.2. UK Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Anti-obesity Drugs Market  

    15.1. Germany Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Anti-obesity Drugs Market  

    16.4. France Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.5. France Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Anti-obesity Drugs Market  

    17.1. Eastern Europe Anti-obesity Drugs Market Overview

    17.2. Eastern Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Anti-obesity Drugs Market  

    18.1. Russia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Anti-obesity Drugs Market  

    19.1. North America Anti-obesity Drugs Market Overview

    19.2. North America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Anti-obesity Drugs Market  

    20.1. USA Anti-obesity Drugs Market Overview

    20.2. USA Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Anti-obesity Drugs Market  

    21.1. South America Anti-obesity Drugs Market Overview

    21.2. South America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Anti-obesity Drugs Market  

    22.1. Brazil Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Anti-obesity Drugs Market  

    23.1. Middle East Anti-obesity Drugs Market Overview

    23.2. Middle East Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Anti-obesity Drugs Market  

    24.1. Africa Anti-obesity Drugs Market Overview

    24.2. Africa Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Anti-obesity Drugs Market Competitive Landscape And Company Profiles

    25.1. Anti-obesity Drugs Market Competitive Landscape

    25.2. Anti-obesity Drugs Market Company Profiles

    25.2.1. F. Hoffmann-La Roche AG,  

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. GlaxoSmithKline PLC,  

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Boehringer Ingelheim GmbH,  

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Pfizer Inc.,

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5.  Merck & Co. Inc.,

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Anti-obesity Drugs Market

    27. Anti-obesity Drugs Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Anti-obesity Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: China, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: China, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: India, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: India, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: Japan, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: Japan, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: Australia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Australia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Indonesia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Indonesia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: South Korea, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: South Korea, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: Western Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Western Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: UK, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: UK, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: Germany, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: Germany, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: France, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: France, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: Russia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: Russia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: North America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: North America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: USA, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: USA, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: South America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: South America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: Brazil, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: Brazil, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Middle East, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Middle East, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Africa, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Africa, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: F. Hoffmann-La Roche AG,  Financial Performance
  • Table 47: GlaxoSmithKline PLC,  Financial Performance
  • Table 48: Boehringer Ingelheim GmbH,  Financial Performance
  • Table 49: Pfizer Inc., Financial Performance
  • Table 50:  Merck & Co. Inc., Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: China, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: China, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: India, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: India, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: Japan, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: Japan, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: Australia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Australia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Indonesia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: South Korea, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: South Korea, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: Western Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: UK, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: UK, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: Germany, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: Germany, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: France, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: France, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: Russia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: Russia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: North America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: North America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: USA, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: USA, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: South America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: South America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: Brazil, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: Brazil, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Middle East, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Middle East, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Africa, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Africa, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: F. Hoffmann-La Roche AG,  Financial Performance
  • Figure 47: GlaxoSmithKline PLC,  Financial Performance
  • Figure 48: Boehringer Ingelheim GmbH,  Financial Performance
  • Figure 49: Pfizer Inc., Financial Performance
  • Figure 50:  Merck & Co. Inc., Financial Performance
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)